Literature DB >> 8564961

Cell cycle synchrony unmasks the influence of p53 function on radiosensitivity of human glioblastoma cells.

G L Yount1, D A Haas-Kogan, C A Vidair, M Haas, W C Dewey, M A Israel.   

Abstract

Although ionizing radiation causes DNA damage that can play a role in tumorigenesis, such irradiation is also an important modality of cancer therapy. We studied the radiation response of the U-87 MG human glioblastoma cell line and transfected derivatives in which p53 function had been inactivated. Although little effect of p53 on the radiation sensitivity of asynchronously growing cultures could be detected, inactivation of p53 resulted in a large increase in clonogenic survival when cells synchronized by mitotic selection were irradiated in early G1. The radiation dose sufficient to reduce cellular clonogenicity by 1 log in cells expressing functional p53 was 3.26 +/- 0.12 Gy, whereas a much higher dose (7.41 +/- 0.44 Gy) was required to achieve the same killing effect in cells in which p53 was inactivated. Apoptosis was excluded as a probable mechanism contributing to the radiosensitivity of these cells. Fluorescence-activated cell sorter analysis, continuous labeling with tritiated thymidine, and time-lapse videomicroscopy documented the first example of a prolonged p53-dependent G1 arrest induced by ionizing radiation during the first postirradiation cell cycle of tumor cells, suggesting a role for G1 arrest in determining the sensitivity of these cells to irradiation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8564961

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  14 in total

Review 1.  "...those left behind." Biology and oncology of invasive glioma cells.

Authors:  M E Berens; A Giese
Journal:  Neoplasia       Date:  1999-08       Impact factor: 5.715

2.  Dexamethasone-induced radioresistance occurring independent of human papilloma virus gene expression in cervical carcinoma cells.

Authors:  H P Rutz; M Mariotta; M von Knebel Doeberitz; R O Mirimanoff
Journal:  Strahlenther Onkol       Date:  1998-02       Impact factor: 3.621

3.  DNA damage and p53-mediated cell cycle arrest: a reevaluation.

Authors:  N S Pellegata; R J Antoniono; J L Redpath; E J Stanbridge
Journal:  Proc Natl Acad Sci U S A       Date:  1996-12-24       Impact factor: 11.205

4.  Overcoming of radioresistance in human gliomas by p21WAF1/CIP1 antisense oligonucleotide.

Authors:  T Kokunai; S Urui; H Tomita; N Tamaki
Journal:  J Neurooncol       Date:  2001-01       Impact factor: 4.130

5.  Adenovirus-mediated p53 gene delivery potentiates the radiation-induced growth inhibition of experimental brain tumors.

Authors:  B Badie; M H Kramar; R Lau; D A Boothman; J S Economou; K L Black
Journal:  J Neurooncol       Date:  1998-05       Impact factor: 4.130

6.  The intrinsic radioresistance of glioblastoma-derived cell lines is associated with a failure of p53 to induce p21(BAX) expression.

Authors:  H K Shu; M M Kim; P Chen; F Furman; C M Julin; M A Israel
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-24       Impact factor: 11.205

7.  Down-regulation of Wilms' tumor 1 expression in glioblastoma cells increases radiosensitivity independently of p53.

Authors:  Aaron J Clark; Dana C Chan; Mike Y Chen; Helen Fillmore; Wagner G Dos Santos; Timothy E Van Meter; Martin R Graf; William C Broaddus
Journal:  J Neurooncol       Date:  2007-01-06       Impact factor: 4.506

8.  Transcriptome analysis of glioma cells for the dynamic response to γ-irradiation and dual regulation of apoptosis genes: a new insight into radiotherapy for glioblastomas.

Authors:  H Ma; L Rao; H L Wang; Z W Mao; R H Lei; Z Y Yang; H Qing; Y L Deng
Journal:  Cell Death Dis       Date:  2013-10-31       Impact factor: 8.469

9.  Assessing the radiation response of lung cancer with different gene mutations using genetically engineered mice.

Authors:  Bradford A Perez; A Paiman Ghafoori; Chang-Lung Lee; Samuel M Johnston; Yifan Li; Jacob G Moroshek; Yan Ma; Sayan Mukherjee; Yongbaek Kim; Cristian T Badea; David G Kirsch
Journal:  Front Oncol       Date:  2013-04-02       Impact factor: 6.244

10.  In vitro test of external Qigong.

Authors:  Garret Yount; Jerry Solfvin; Dan Moore; Marilyn Schlitz; Melissa Reading; Ken Aldape; Yifang Qian
Journal:  BMC Complement Altern Med       Date:  2004-03-15       Impact factor: 3.659

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.